πŸ‡ΊπŸ‡Έ FDA
Patent

US 11958840

Compounds, compositions and methods

granted A61PA61P25/00A61P25/28

Quick answer

US patent 11958840 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61P, A61P25/00, A61P25/28, A61P35/00